The combination of capsaicin and sorafenib seems promising in the treatment of HCC, as the two substances act concurrently on inducing apoptosis and preventing cellular proliferation, while capsaicin also prevents the development of resistance to sorafenib by targeting the PI3K/Akt pathway [114]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.